Talquetamab Bridging Strategy Appears Feasible in R/R Multiple Myeloma
Written by
Cancer Network
Published
0
comments
0
min
Bridging therapy with talquetamab achieved “notable” disease control among patients with multiple myeloma in a retrospective study.